Advanced search
Publication Cover
Clinical and Experimental Gastroenterology Volume 7, 2014 - Issue
Submit an article Journal homepage
450
Views
70
CrossRef citations to date
0
Altmetric
Review

Molecular pathways in non-alcoholic fatty liver disease

Alba Berlanga1 Group GEMMAIR (AGAUR) and Applied Medicine Research Group, Department of Medicine and Surgery, Universitat Rovira i Virgili (URV), IISPV, Hospital Universitari Joan XXIII, Tarragona, Spain
,
Esther Guiu-Jurado1 Group GEMMAIR (AGAUR) and Applied Medicine Research Group, Department of Medicine and Surgery, Universitat Rovira i Virgili (URV), IISPV, Hospital Universitari Joan XXIII, Tarragona, Spain
,
José Antonio Porras1 Group GEMMAIR (AGAUR) and Applied Medicine Research Group, Department of Medicine and Surgery, Universitat Rovira i Virgili (URV), IISPV, Hospital Universitari Joan XXIII, Tarragona, Spain;2 Department of Internal Medicine, Hospital Universitari Joan XXIII Tarragona, Tarragona, Spain
&
Teresa Auguet1 Group GEMMAIR (AGAUR) and Applied Medicine Research Group, Department of Medicine and Surgery, Universitat Rovira i Virgili (URV), IISPV, Hospital Universitari Joan XXIII, Tarragona, Spain;2 Department of Internal Medicine, Hospital Universitari Joan XXIII Tarragona, Tarragona, SpainCorrespondence[email protected]
Pages 221-239 | Published online: 05 Jul 2014

Citations (70)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Amir Abbas Momtazi-Borojeni, Maciej Banach, Massimiliano Ruscica & Amirhossein Sahebkar. (2022) The role of PCSK9 in NAFLD/NASH and therapeutic implications of PCSK9 inhibition. Expert Review of Clinical Pharmacology 15:10, pages 1199-1208.
Read now
Aline Maria Nunes de Lira Gomes Bloise, Aiany Cibelle Simões-Alves, Alves Debora Santos, Beatrice Morio & João Henrique Costa-Silva. (2022) Cardiometabolic impacts of saturated fatty acids: are they all comparable?. International Journal of Food Sciences and Nutrition 73:1, pages 1-14.
Read now
Ellen Nogueira-Lima, Celina de Almeida Lamas, Andressa Mara Baseggio, Jéssica Stephany Fernandes do Vale, Mário Roberto Maróstica Junior & Valéria Helena Alves Cagnon. (2020) High-fat diet effects on the prostatic adenocarcinoma model and jaboticaba peel extract intake: protective response in metabolic disorders and liver histopathology. Nutrition and Cancer 72:8, pages 1366-1377.
Read now
Yun Hu, Yue Feng, Luchu Zhang, Yimin Jia, Demin Cai, Shu-Bing Qian, Min Du & Ruqian Zhao. (2020) GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m6A on lipogenic mRNAs. RNA Biology 17:7, pages 930-942.
Read now
Shaoren Zhang, Yuqing Mao & Xiaoming Fan. (2018) Inhibition of ghrelin o-acyltransferase attenuated lipotoxicity by inducing autophagy via AMPK–mTOR pathway. Drug Design, Development and Therapy 12, pages 873-885.
Read now
Xiaoxue Zhang, Renpeng Ji, Huijun Sun, Jinyong Peng, Xiaodong Ma, ChangYuan Wang, Yufeng Fu, Liuchi Bao & Yue Jin. (2018) Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway. Free Radical Research 52:2, pages 198-211.
Read now
Juan Li, Auke P Verhaar, Qiuwei Pan, Robert Jacobus de Knegt & Maikel P Peppelenbosch. (2017) Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B. Clinical and Experimental Gastroenterology 10, pages 203-209.
Read now
Mahmoud Hussein Hassan Ali, Basim Anwar Shehata Messiha & Hekma Abdel-Tawab Abdel-Latif. (2016) Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats. Pharmaceutical Biology 54:7, pages 1198-1208.
Read now
David E. Amacher. (2014) Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease. Biomarkers 19:7, pages 541-552.
Read now

Articles from other publishers (61)

Tamilmani Periyasamy, V. V. Sathibabu Uddandrao, Chandrasekaran Ponnusamy, Saravanan Ganapathy, Sethumathi Ponnusamy Pudhupalayam, Sengottuvelu Singaravel, Ponmurugan Ponnusamy, Jagadeesan Ramasamy, Kalaivani Aiyasamy & Vadivukkarasi Sasikumar. (2023) Linalool Mitigated High-Fat Diet–Induced Non-alcoholic Fatty Liver Disease by Regulating the Intestinal-Hepatic Axis via TGF-β/NF-kB/TLR4/ZO-1 Pathway. Revista Brasileira de Farmacognosia 33:3, pages 617-628.
Crossref
Shu Niu, Shuchun Chen, Xing Chen, Qingjuan Ren, Lin Yue, Xiaoyu Pan, Huiying Zhao, Zelin Li & Xiaoyi Chen. (2022) Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model. Frontiers in Endocrinology 13.
Crossref
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Ramkumar Katturajan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri & Sabina Evan Prince. (2022) Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs. Cells 11:24, pages 3959.
Crossref
Yamei Duan, Jiayou Luo, Xiongfeng Pan, Jia Wei, Xiang Xiao, Jingya Li & Miyang Luo. (2022) Association between inflammatory markers and non-alcoholic fatty liver disease in obese children. Frontiers in Public Health 10.
Crossref
Muhammad Umair Latif, Geske Elisabeth Schmidt, Sercan Mercan, Raza Rahman, Christine Silvia Gibhardt, Ioana Stejerean-Todoran, Kristina Reutlinger, Elisabeth Hessmann, Shiv K Singh, Abdul Moeed, Abdul Rehman, Umer Javed Butt, Hanibal Bohnenberger, Philipp Stroebel, Sebastian Christopher Bremer, Albrecht Neesse, Ivan Bogeski & Volker Ellenrieder. (2022) NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression. Gut 71:12, pages 2561-2573.
Crossref
Wei Wei, Liming Liu, Xiaokang Liu, Ye Tao, Jiyu Gong, Yang Wang & Shuying Liu. (2022) Black ginseng protects against Western diet‐induced nonalcoholic steatohepatitis by modulating the TLR4/NF‐κB signaling pathway in mice. Journal of Food Biochemistry 46:12.
Crossref
Ling Ruan, Guanghua Wang, Zhen Qing Lv, Shoubang Li, Qin Liu, Yiling Ren, Quancheng Zhang, Xianli Lv, Rongping Wu & Zhan Ji. (2022) The effect of varied exercise intensity on antioxidant function, aortic endothelial function, and serum lipids in rats with non-alcoholic fatty liver disease.. Investigación Clínica 63:4, pages 327-343.
Crossref
Wen YanranSoohan JungKwang Suk Ko. (2022) Saturated Fatty Acid-Induced Impairment of Hepatic Lipid Metabolism Is Worsened by Prohibitin 1 Deficiency in Hepatocytes. Journal of Medicinal Food 25:8, pages 845-852.
Crossref
Jihad Aljabban, Michael Rohr, Saad Syed, Kamal Khorfan, Vincent Borkowski, Hisham Aljabban, Michael Segal, Mohamed Mukhtar, Mohammed Mohammed, Maryam Panahiazar, Dexter Hadley, Ryan Spengler & Erin Spengler. (2022) Transcriptome changes in stages of non-alcoholic fatty liver disease. World Journal of Hepatology 14:7, pages 1382-1397.
Crossref
Alberto Nascè, Karim Gariani, François R. Jornayvaz & Ildiko Szanto. (2022) NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook. Antioxidants 11:6, pages 1131.
Crossref
Achille Parfait Nwakiban Atchan, Shilpa Talkad Shivashankara, Stefano Piazza, Armelle Deutou Tchamgoue, Giangiacomo Beretta, Mario Dell’Agli, Paolo Magni, Gabriel Agbor Agbor, Jules-Roger Kuiaté & Uma Venkateswaran Manjappara. (2022) Polyphenol-Rich Extracts of Xylopia and Aframomum Species Show Metabolic Benefits by Lowering Hepatic Lipid Accumulation in Diet-Induced Obese Mice. ACS Omega 7:14, pages 11914-11928.
Crossref
Zhendong Sun, Zhi Tang, Xiaoxi Yang, Qian S. Liu, Jianqing Zhang, Qunfang Zhou & Guibin Jiang. (2022) 3- tert -Butyl-4-hydroxyanisole Impairs Hepatic Lipid Metabolism in Male Mice Fed with a High-Fat Diet . Environmental Science & Technology 56:5, pages 3204-3213.
Crossref
Esraa SA Ahmed, Hebatallah E Mohamed & Mostafa A Farrag. (2022) Luteolin loaded on zinc oxide nanoparticles ameliorates non-alcoholic fatty liver disease associated with insulin resistance in diabetic rats via regulation of PI3K/AKT/FoxO1 pathway . International Journal of Immunopathology and Pharmacology 36, pages 039463202211374.
Crossref
Zaida Zakaria, Zaidatul Akmal Othman, Joseph Bagi Suleiman, Nur Asyilla Che Jalil, Wan Syaheedah Wan Ghazali, Victor Udo Nna & Mahaneem Mohamed. (2021) Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation. Antioxidants 10:12, pages 2031.
Crossref
Siwen Zhang, Xiaokun Gang, Shuo Yang, Mengzhao Cui, Lin Sun, Zhuo Li & Guixia Wang. (2021) The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases. Frontiers in Immunology 12.
Crossref
Saroj Khatiwada, Virginie Lecomte, Michael F. Fenech, Margaret J. Morris & Christopher A. Maloney. (2021) Effects of Micronutrient Supplementation on Glucose and Hepatic Lipid Metabolism in a Rat Model of Diet Induced Obesity. Cells 10:7, pages 1751.
Crossref
Nilay D. SolankiKirti VadiSandip Patel. (2021) Alleviating effect of Ficus racemosa in high-fat-high-fructose diet-induced non-alcoholic fatty liver disease . Indian Journal of Physiology and Pharmacology 65, pages 12-20.
Crossref
Lydie Carreres, Zuzana Macek Jílková, Guillaume Vial, Patrice N. Marche, Thomas Decaens & Hervé Lerat. (2021) Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review. Biomedicines 9:4, pages 378.
Crossref
Snizhana V. Feysa & Svitlana O. Rudakova. (2021) INFLUENCE OF COMPLEX TREATMENT ON BIOCHEMICAL BLOOD PARAMETERS OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND CONCOMITANT PRE-DIABETES. Wiadomości Lekarskie 74:4, pages 986-991.
Crossref
Ling Ruan, Fanghui Li, Shoubang Li, Mingjun Zhang, Feng Wang, Xianli Lv & Qin Liu. (2021) Effect of Different Exercise Intensities on Hepatocyte Apoptosis in HFD-Induced NAFLD in Rats: The Possible Role of Endoplasmic Reticulum Stress through the Regulation of the IRE1/JNK and eIF2α/CHOP Signal Pathways. Oxidative Medicine and Cellular Longevity 2021, pages 1-15.
Crossref
Sung Rye Park, Chun-Seok Cho, Jingyue Xi, Hyun Min Kang & Jun Hee Lee. (2021) Holistic characterization of single-hepatocyte transcriptome responses to high-fat diet. American Journal of Physiology-Endocrinology and Metabolism 320:2, pages E244-E258.
Crossref
Jin Wang, Wanping He, Ping-Ju Tsai, Pei-Hsuan Chen, Manxiang Ye, Jiao Guo & Zhengquan Su. (2020) Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease. Lipids in Health and Disease 19:1.
Crossref
Marina Galicia-Moreno, Silvia Lucano-Landeros, Hugo Christian Monroy-Ramirez, Jorge Silva-Gomez, Jorge Gutierrez-Cuevas, Arturo Santos & Juan Armendariz-Borunda. (2020) Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects. Antioxidants 9:10, pages 980.
Crossref
Xulong Sun, Ruifang Chen, Guangyu Yan, Zhiheng Chen, Hong Yuan, Wei Huang & Yao Lu. (2020) Gender-specific associations between apolipoprotein A1 and arterial stiffness in patients with nonalcoholic fatty liver disease. PeerJ 8, pages e9757.
Crossref
Myoung Ki Cho, Min Ji Seo, Vinayak Juvekar, Jae Hyung Jo, Wontae Kim, Kyeong Sook Choi & Hwan Myung Kim. (2020) Screening of Drug-Induced Steatosis and Phospholipidosis Using Lipid Droplet-Selective Two-Photon Probes. Analytical Chemistry 92:16, pages 11223-11231.
Crossref
Suryaprakash Raichur. (2020) Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases. Frontiers in Endocrinology 11.
Crossref
Samuele Bovo, Pier Luigi Martelli, Pietro Di Lena & Rita Casadio. (2020) NETGE-PLUS: Standard and Network-Based Gene Enrichment Analysis in Human and Model Organisms. Journal of Proteome Research 19:7, pages 2873-2878.
Crossref
Li Zhong, Jianghan Yuan, Lu Huang, Shan Li & Liang Deng. (2020) RANKL Is Involved in Runx2-Triggered Hepatic Infiltration of Macrophages in Mice with NAFLD Induced by a High-Fat Diet. BioMed Research International 2020, pages 1-8.
Crossref
Jinghua Du, Weiguang Ren, Qingshan Zhang, Na Fu, Fang Han, Po Cui, Wencong Li, Lingbo Kong, Suxian Zhao, Rongqi Wang, Yuguo Zhang, Luting Yang, Li Kong & Yuemin Nan. (2020) Heme Oxygenase-1 Suppresses Wnt Signaling Pathway in Nonalcoholic Steatohepatitis-Related Liver Fibrosis. BioMed Research International 2020, pages 1-15.
Crossref
Mengting Zhou, Naihua Hu, Meichen Liu, Ying Deng, Linfeng He, Chaocheng Guo, Xingtao Zhao & Yunxia Li. (2020) A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori Radix. BioMed Research International 2020, pages 1-19.
Crossref
Safaa A. Faheem, Noha M. Saeed, Reem N. El-Naga, Iriny M. Ayoub & Samar S. Azab. (2020) Hepatoprotective Effect of Cranberry Nutraceutical Extract in Non-alcoholic Fatty Liver Model in Rats: Impact on Insulin Resistance and Nrf-2 Expression. Frontiers in Pharmacology 11.
Crossref
Yuka Murata, Takashi Yamashiro, Takaomi Kessoku, Israt Jahan, Haruki Usuda, Tetsuya Tanaka, Takayuki Okamoto, Atsushi Nakajima & Koichiro Wada. (2019) Up-Regulated MicroRNA-27b Promotes Adipocyte Differentiation via Induction of Acyl-CoA Thioesterase 2 Expression. BioMed Research International 2019, pages 1-9.
Crossref
I.I. Nefyodov, A.J. Karakosh, M.A. Alufaini, P.A. Karavay & N.L. Karavay. (2019) Amino Acids and their Derivatives in Pathogenesis and Treatment of Liver Diseases. Journal of Hematology and Oncology Research 3:3, pages 1-8.
Crossref
Maria Guarino & Jean-François Dufour. (2019) Nicotinamide and NAFLD: Is There Nothing New Under the Sun?. Metabolites 9:9, pages 180.
Crossref
Michelle L Boland, Denise Oró, Kirstine S Tølbøl, Sebastian T Thrane, Jens Christian Nielsen, Taylor S Cohen, David E Tabor, Fiona Fernandes, Andrey Tovchigrechko, Sanne S Veidal, Paul Warrener, Bret R Sellman, Jacob Jelsing, Michael Feigh, Niels Vrang, James L Trevaskis & Henrik H Hansen. (2019) Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source. World Journal of Gastroenterology 25:33, pages 4904-4920.
Crossref
Davide Cangelosi, Roberta Resaz, Andrea Petretto, Daniela Segalerba, Marzia Ognibene, Federica Raggi, Luca Mastracci, Federica Grillo, Maria Carla Bosco, Luigi Varesio, Antonio Sica, Irma Colombo & Alessandra Eva. (2019) A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization. Journal of Proteome Research 18:7, pages 2965-2978.
Crossref
Malte P. Suppli, Kristoffer T. G. Rigbolt, Sanne S. Veidal, Sara Heebøll, Peter Lykke Eriksen, Mia Demant, Jonatan I. Bagger, Jens Christian Nielsen, Denise Oró, Sebastian W. Thrane, Asger Lund, Charlotte Strandberg, Merete J. Kønig, Tina Vilsbøll, Niels Vrang, Karen L. Thomsen, Henning Grønbæk, Jacob Jelsing, Henrik H. Hansen & Filip K. Knop. (2019) Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. American Journal of Physiology-Gastrointestinal and Liver Physiology 316:4, pages G462-G472.
Crossref
Grietje Prins, Theerut Luangmonkong, Dorenda Oosterhuis, Henricus Mutsaers, Frank Dekker & Peter Olinga. (2019) A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices. Nutrients 11:3, pages 507.
Crossref
Daniel Pfirrmann, Yvonne Huber, Jörn Markus Schattenberg & Perikles Simon. (2019) Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study. Journal of Medical Internet Research 21:1, pages e11250.
Crossref
Ran Nagahara, Tomomitsu Matono, Takaaki Sugihara, Yukako Matsuki, Masafumi Yamane, Toshiaki Okamoto, Kenichi Miyoshi, Takakazu Nagahara, Jun-ichi Okano, Masahiko Koda & Hajime Isomoto. (2019) Gene Expression Analysis of the Activating Factor 3/Nuclear Protein 1 Axis in a Non-alcoholic Steatohepatitis Mouse Model. Yonago Acta Medica 62:1, pages 036-046.
Crossref
Maddalena Parafati, R. Jason Kirby, Sepideh Khorasanizadeh, Fraydoon Rastinejad & Siobhan Malany. (2018) A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis. Disease Models & Mechanisms 11:9.
Crossref
Alexandre Abilio de Souza Teixeira, Camila O. Souza, Luana A. Biondo, Loreana Sanches Silveira, Edson A. Lima, Helena A. Batatinha, Adriane Pereira Araujo, Michele Joana Alves, Sandro Massao Hirabara, Rui Curi & José Cesar Rosa Neto. (2018) Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice. Inflammopharmacology 26:4, pages 1103-1115.
Crossref
FX Himawan Haryanto Jong, Ari Gunawan, Mochamad Wirono Aman Santoso, Susilowati Anjani, Ni Wayan Tirthaningsih & Ahmad Basori. (2018) Effects of Sambiloto Ethanol Extract on Fatty Liver, SGOT/SGPT Levels and Lipid Profile of Wistar Strain White Rat (Rattus norvegicus) Exposed to High-Fat Diet. Folia Medica Indonesiana 54:2, pages 89.
Crossref
Jiapeng Chen, Alexandra Montagner, Nguan Tan & Walter Wahli. (2018) Insights into the Role of PPARβ/δ in NAFLD. International Journal of Molecular Sciences 19:7, pages 1893.
Crossref
Sara Shojaei Zarghani, Samin Abbaszadeh, Mohammad Alizadeh, Maryam Rameshrad, Alireza Garjani & Hamid Soraya. (2018) The Eeffect of Metformin Combined with Calcium-Vitamin D3 Against Diet-Induced Nonalcoholic Fatty Liver Disease. Advanced Pharmaceutical Bulletin 8:1, pages 97-105.
Crossref
Kirstine S Tølbøl, Maria NB Kristiansen, Henrik H Hansen, Sanne S Veidal, Kristoffer TG Rigbolt, Matthew P Gillum, Jacob Jelsing, Niels Vrang & Michael Feigh. (2018) Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis. World Journal of Gastroenterology 24:2, pages 179-194.
Crossref
Narjes Khavasi, Mohammad hosein Somi, Ebrahim Khadem, Elnaz Faramarzi, Mohammad Hossein Ayati, Seyyed Muhammad Bagher Fazljou & Mohammadali Torbati. (2017) Effect of Daily Caper Fruit Pickle Consumption on Disease Regression in Patients with Non-Alcoholic Fatty Liver Disease: a Double-Blinded Randomized Clinical Trial. Advanced Pharmaceutical Bulletin 7:4, pages 645-650.
Crossref
Magdalena IzdebskaIwona Piątkowska-ChmielAgnieszka KorolczukMariola HerbetMonika Gawrońska-GrzywaczRenata GierobaMarcin SysaKlaudia Czajkowska-BaniaMarcelina CygalAgnieszka KorgaJarosław Dudka. (2017) The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells. Canadian Journal of Physiology and Pharmacology 95:12, pages 1442-1453.
Crossref
Guillaume Arguin, Jean-François Bourzac, Morgane Placet, Caroline M. Molle, Michel Paquette, Jean-François Beaudoin, Jacques A. Rousseau, Roger Lecomte, Mélanie Plourde & Fernand-Pierre Gendron. (2017) The loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis. Scientific Reports 7:1.
Crossref
Giulia Vecchione, Elena Grasselli, Federica Cioffi, Francesca Baldini, Paulo J. Oliveira, Vilma A. Sardão, Katia Cortese, Antonia Lanni, Adriana Voci, Piero Portincasa & Laura Vergani. (2017) The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an In Vitro Model of Non-Alcoholic Fatty Liver Disease Progression. Frontiers in Nutrition 4.
Crossref
Rosalba Senese, Federica Cioffi, Pieter de Lange, Cristina Leanza, Liliana F. Iannucci, Elena Silvestri, Maria Moreno, Assunta Lombardi, Fernando Goglia & Antonia Lanni. (2017) Both 3,5-Diiodo-L-Thyronine and 3,5,3′-Triiodo-L-Thyronine Prevent Short-term Hepatic Lipid Accumulation via Distinct Mechanisms in Rats Being Fed a High-Fat Diet. Frontiers in Physiology 8.
Crossref
Bahareh Amirkalali, Masoud Reza Sohrabi, Parvaneh Rahimi-Moghaddam, Ali Esrafily, Ali Gholami, Payam Hosseinzadeh, Hossein Keyvani, Farzad Shidfar & Farhad Zamani. (2017) The Association of Nicotinamide Phosphoribosyltransferase Polymorphism with Markers of Hepatic Injury and De Novo Lipogenesis in Nonalcoholic Fatty Liver Disease. Hepatitis Monthly 17:6.
Crossref
Vanessa Souza-Mello. (2017) Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade. World Journal of Hepatology 9:2, pages 74.
Crossref
Juan-Juan Gu, Min Yao, Jie Yang, Yin Cai, Wen-Jie Zheng, Li Wang, Deng-Bing Yao & Deng-Fu Yao. (2017) Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis. World Journal of Gastroenterology 23:2, pages 256.
Crossref
Atilla Engin. 2017. Obesity and Lipotoxicity. Obesity and Lipotoxicity 443 467 .
Jake P. Mann, Robert K. Semple & Matthew J. Armstrong. (2016) How Useful Are Monogenic Rodent Models for the Study of Human Non-Alcoholic Fatty Liver Disease?. Frontiers in Endocrinology 7.
Crossref
Shyrlene Araújo, Amanda Soares e Silva, Fabiana Gomes, Edlene Ribeiro, Wilma Oliveira, Amanda Oliveira, Ingrid Lima, Maria do Carmo Lima, Ivan Pitta & Christina Peixoto. (2016) Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD). European Journal of Pharmacology 788, pages 306-314.
Crossref
Shereen Ezzelregal Alashry, Mohammad A. Gaballah, Hala Abdel Malek & Adel I. Abd Elsalam. (2015) Effect of Sildenafil on Non-Alcoholic Fatty Liver. International Journal of Pharmacology 11:7, pages 814-820.
Crossref
Giulia Ganzetti. (2015) Non-alcoholic fatty liver disease and psoriasis: So far, so near. World Journal of Hepatology 7:3, pages 315.
Crossref
Omar Ramos-Lopez. (2015) Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World Journal of Gastroenterology 21:41, pages 11552.
Crossref
Sonia Roman. (2015) Genomic medicine in gastroenterology: A new approach or a new specialty?. World Journal of Gastroenterology 21:27, pages 8227.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.